Efficacy and toxicity of post-neoadjuvant trastuzumab emtansine in HER2-positive breast cancer patients treated at Institut Curie Hospitals. - De Moura, Alexandre; Gleizes, Orane; Cabel, Luc; Bethune-Volters, Anne; Bellesoeur, Audrey; Bello-Roufai, Diana; Cottu, Paul; Sebbag, Clara; Loirat, Delphine; Geiss, Romain; Pierga, Jean-Yves; Escalup, Laurence; et al. (Scientific Reports, 2025)